Healthcare & Life Sciences
Pheast Therapeutics
United Stateswww.pheast.com
Pheast Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 1 tracked investor.
Activeseries-a
series-a
Stage
2018
Founded
1
Investors
About Pheast Therapeutics
Pheast Therapeutics is a startup founded in 2018 based in the United States. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Pheast Therapeutics is a clinical-stage biotechnology company focused on developing macrophage-directed immunotherapies for cancer. Their lead candidate, PHST001, is an anti-CD24 monoclonal antibody designed to block a key immune checkpoint and enhance macrophage-mediated tumor clearance.
Explore Pheast Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.